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Abstract
Background: Telocytes are specialized interstitial tissue cell type. Our aim is to characterize telocytes in human
uterine leiomyoma (ULM) and its adjacent myometrium (Myo-F) as well as normal myometrium (Myo-N).
Methods: ULMs and Myo-F tissues were taken from hysterectomy specimens done to treat symptomatic uterine
fibroids (N = 20). Myo-N is isolated from hysterectomies done on ULM- free uteri for other benign indications (N = 15).
Telocytes were detected using immunohistochemistry to detect c-Kit (CD-117), as a surface marker expressed on
telocytes, and electron microscopic examination to identify telocytes characteristic ultrastructure. Cellular count and
electron microscopic features of telocytes in each of the studied tissues were compared.
Results: Telocytes could be detected in ULMs, Myo-F and Myo-N using c-KIT immunostaining. Electron microscopy
confirmed the presence of telocytes in the three types of tissues identifying their characteristic features including small
triangular or fusiform cell bodies with extensive cellular prolongations. ULM telocytes showed ultrastructural features
suggestive of high cellular activities. Cell counts of ULM telocytes (3.35 ± 0.39) were significantly higher (P value = 0.
00039) than that of Myo-F (1.39 ± 0.13). Myo-N (2.6 ± 0.36) contained higher telocyte numbers than Myo-F (1.39 ± 0.13),
but the difference did not reach statistical significance (P value = 0.19).
Conclusions: Telocytes are detected in higher numbers and activity in ULMs than Myo-F or Myo-N. In ULMs, telocytes
can work as a hormonal sensors for stem cells, provide scaffold for newly formed myocytes, or control important
downstream signaling pathways.
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Background
Uterine leiomyomas (ULMs) are benign, monoclonal
neoplasms of the myometrium [1]. They are present in
up to 77 % of pathologically examined hysterectomy
specimens [2]. Their cumulative incidence at age of
50 years is 80 % for African American women and 70 %
for White women [3, 4]. ULMs are a significant cause of
pelvic pain, abnormal uterine bleeding, infertility, and
pregnancy complications [5]. There is no effective long
term medical treatment for women with ULMs [6]. In
the US, around 200,000 hysterectomies and 30,000 myo-
mectomies are performed annually to treat such women
[7], with annual costs of 4.9 to 34.6 billion USD [8].
The myometrium, which gives origin to ULM, consists
of two main cell types; myometrial and interstitial cells.
Among interstitial cells, Telocytes have recently been de-
scribed [9, 10]. Under electron microscope, telocytes
have a small, oval, or triangular-shaped body. Their
characteristic feature is the presence of very long pro-
longations called telopodes, usually two to five per cell
[11–13]. Telocytes have been described in the stroma of
several major organs as heart [14–16], skeletal muscles
[17], vessels [18], placenta [19], small intestine [9], and
lungs [20]. Telocytes, via direct cell body and with their
long branching telopodes, make a 3D network of homo-
cellular or heterocellular contacts [11, 21].
Telocytes may function as a scaffold to define the
correct organization of extracellular matrix during tissue
repair/renewal [12, 22]. They may also participate in
intercellular signaling, immune surveillance and tissue
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regeneration [21]. Telocytes show waves of depolarization
and may participate in spreading the slow waves generated
by the pacemaker interstitial cells of Cajal (ICC) in the
GIT [23].
In the female genital tract, telocytes have been described
in the placenta [19], endometrium [24] and myometrium
[10, 25, 26]. However, to the best of our knowledge, this
cell type has never been identified in uterine leiomyoma,
despite that a considerable interest is currently being given
to the potential role of telocytes in pathological conditions
of different organ systems [27–29].
Methods
Human tissue
Samples of ULMs and Myo-F were taken from women
undergoing hysterectomy for the treatment of ULMs
(n = 20). Hysterectomy patients (n = 20) were premen-
opausal (age range 40–44 years) and in proliferative
phase of the menstrual cycle. Fibroids were diagnosed
preoperatively using ultrasound and confirmed after
surgery with histopathological evaluation. We included
other 15 myometrial samples obtained from women
undergoing hysterectomy for benign indications other
than ULMs (irregular bleeding, chronic pelvic pain and
uterine prolapse) as control samples (Myo-N). Women
from whom Myo-N were obtained were operated upon in
the proliferative phase, and were of comparable age group
to the ULMs group (premenopausal). Cycle phase was de-
termined using patient’s menstrual history and histopath-
ology of endometrial samples. All patients gave their
informed consent and Assiut Faculty of Medicine Review
Board approved the use of human tissues for the study.
Immunohistochemistry
The presence CD117 protein (c-Kit) was analyzed by
immunohistochemical staining using the avidin-biotin
immunoperoxidase complex technique.
Immunohistochemistry was performed as manufacturer’s
protocol. Tissue sections (4-μm thick) of formalin-fixed,
paraffin-embedded specimens were cut. The sections were
deparaffinized, rehydrated in graded alcohol, and endogen-
ous peroxidase were blocked by the use of 3 % hydrogen
peroxide in methanol for 5 min. Antigen retrieval was done
by immersing the slides in citrate buffer and putting them
in microwave for 20 min. Samples were then incubated
overnight at room temperature with primary antibody for
CD117/c-kit (rabbit polyclonal antibody, Thermo scientific,
Fremont, CA, cat. no. RB-1518-P0) at a dilution of 1:100.
We then used a secondary antibody detection system
(Ultravision detection system, Anti-polyvalent, HRP/DAB,
Thermo scientific, Fremont, CA, cat. no. TP-015-HD). This
was followed by slide developing using 3-3′-diamino-
benzidine chromogen and counterstained with Mayer’s
hematoxylin. Negative control slides were done by
omitting the primary antibody. Sections from gastro-
intestinal stromal tumor (GIST) were stained as a
positive control.
Evaluation of immunohistchemistry
Stained slides were examined to identify the number of
c-KIT positive cells in high power field. For each section
10 non-overlapping randomly selected high power fields
were counted and then the average was calculated.
Electron microscopic examination
Small pieces (1 mm) of leiomyoma and myometrial tis-
sues from patients and controls were excised. Tissue
pieces were fixed in 2.5 % glutaraldehyde solution at at
4c for 24 h and washed overnight in several changes of
0.1 mol/l sodium phosphate buffer (pH 7.4) at 4C. Later
they were postfixed in 2 % osmium tetraoxide in
0.1 mol/l sodium phosphate buffer at room temperature.
The specimens were dehydrated in ascending grades of
cold ethanol, and then embedded in epoxy resin. Semi-
thin sections (0.5–1-μm-thick) were cut on a Reichert
Ultracut ultramicrotome and stained with 1 % (w/v)
toluidine blue in 1 % (w/v) borax for evaluation. Ultra-
thin sections (70–90 nm) of selected areas of osmicated
tissues were cut with a diamond knife, mounted on 200-
mesh copper grids and contrasted with 3 % aqueous ur-
anyl acetate for 10 min then in lead citrate for 5 min.
The sections were then examined and photographed
using a transmission electron microscope JEOL (JEM-
100 CXII, Akishima, Tokyo, Japan) and photographed at
80 kV in Assiut University, Electron Microscope Unit.
Statistical analysis
Average numbers of C-kit positive cells in the three tis-
sue groups (uterine leiomyoma, myometrium adjacent to
leiomyom and control myometrium) were compared
using Student-t-test. Data were expressed as mean ±
standard error of the mean (SEM).
Results
Light microscopic results
Expression of transmembrane surface receptor c-KIT
(CD-117) is characteristic for telocytes in the human
myometrium. Few scattered c-kit-positive telocytes were
detected among smooth muscle cells of the Myo-N.
They appeared as small fusiform cells or cells with
scanty cytoplasm and large flat nuclei. Long cytoplasmic
processes that extend from the poles of the cell body
were identified (telopodes) (Fig. 1a). Mast cells were also
immunopositive for c-KIT (CD 117), but can be recog-
nized by their characteristic morphology. They had large
rounded nuclei and granular cytoplasm (Fig. 1b). In
Myo-F; telocytes were well identified in intimate relation
to blood vessels (Fig. 1c). In ULM tissues, the c-KIT
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positive telocytes as well as mast cells were identified ad
found to be located either parallel to myocytes or in re-
lations to blood vessels (Fig. 1d).
Ultrastructural results
Telocytes are distinguished in the present work in the
interstitial space between smooth muscle cells. Ultrastruc-
tural examination of Myo-N showed that a telocyte have
pyriform shape cell body with cellular prolongations ex-
tending from either sides of the cell called telopodes. The
cell body contains an euchromatic nucleus with clusters of
peripheral heterochromatin clumps. The nucleus is sur-
rounded by a small amount of cytoplasm rich in mito-
chondria and rough endoplasmic reticulum. Telopodes
exhibit the presence of podomeres (extremely thin seg-
ments) and podoms (dilated portions) (Fig. 2a and inset).
Uterine telocytes detected in Myo-F lie around smooth
muscle cells or in the viscinity of blood capillaries
(Fig. 2b). Their nuclei showed well defined nucleoli. Tel-
opodes run in labrynthine manner and shed vesicles
were abundant (Fig. 2b).
Ultrathin sections of ULM showed telocytes with ex-
tremely long telopodes wich achieved contact between
different telocytes. Their nuclei were euchromatic,. The
cytoplasm was rich in mitochondria, dilated rough endo-
plasmic reticulum cisternae, microfilaments, caveoli, and
shed vesicles (Fig. 2c and d).
Cell counting
Under light microscope, c-KIT positive telocytes, with
their characteristic morphology, were counted in 10 high
power fields and averaged for each of ULM, Myo-F, and
Fig. 1 a A photomicrograph of a section in the control myometrium showing c-kit positive spindle shape telocytes (arrow) among smooth
muscle cells. Original magnification ×1000. b Another section of the control myometrium showing c-kit-positive mast cell (arrow). It is well demarcated
by its large rounded nucleus and voluminous cytoplasm. Original magnification ×1000. c A photomicrograph of a section in the myometrium adjacent
to uterine leiomyoma showing many c-kit positive telocytes with their long extending telopodes extending from the cell body (arrow). Notice their
intimate relation to blood vessels. Original magnification ×1000. d A photomicrograph of a section in the uterine leiomyoma showing c-kit positive
telocyte parallel to smooth muscle cells (arrow). Original magnification ×1000. e Another section in the uterine leiomyoma showing C-kit-positive mast
cell with voluminous granular cytoplasm (black arrow). Original magnification ×1000
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Myo-N. The highest telocyte cell numbers were identi-
fied in ULM tissues (3.35 ± 0.39), whereas Myo-F
showed the fewest number of telocytes (1.39 ± 0.13).
Myo-N exhibited an intermediate telocyte cell number
(2.6 ± 0.36). On comparing the three studied tissue
groups, significantly higher telocyte numbers were de-
tected in ULM as compared to Myo-F. No significant
difference was found between Myo-F and Myo-N, or
between ULM and Myo-N (Fig. 3).
Discussion
ULMs, despite being the most common gynecologic
tumors, and associated with significant reproductive
morbidity, their exact etiology is not understood.
In the present study, we have characterized, for the
first time to the best of our knowledge, a specialized
interstitial cell type; telocytes; in ULM and Myo-F. Our
results show that as compared to Myo-F or Myo-N,
ULMs contain higher number of telocytes with ultrastruc-
tural features suggestive of increased cellular activity in-
cluding loss of the heterochromation clumps, extremely
Fig. 2 a An electron micrograph of a telocyte (TC) of the control myometrium showing; pyriform shaped cell body with an oval euchromatic
nucleus (N), cytoplasm accommodates mitochondria (m) and endoplasmic reticulum (ER) and thin long processes or telopodes (tp) with
alternating podomers (black arrows) and podoms (white arrow). Original magnification ×3600, Inset ×14,000. b An electron micrograph of
myometrium adjacent to uterine leiomyoma showing a triangular shaped telocyte (TC) with numerous shed vesicles (v) observed near the
telopodes (tp). Original magnification is ×3600. c An electron micrograph of uterine leiomyoma showing multiple telocytes (TC) with their long
telopodes (tps) in a labyrinthine configuration among muscle cells. Intercellular junction exists between telopodes of different telocytes (black
arrows). Original magnification is ×2900. d Higher magnification of telopodes show dilated rough endoplasmic reticulum cisternae (rER),












Fig. 3 Average count of c-Kit positive telocytes per high power field
in uterine leiomyoma (ULM), myometrium adjacent to leiomyoma
(Myo-F), and normal myometrium (Myo-N). * denotes significantly
higher cell number as compared to myometrium adjacent to
leiomyoma (Myo-F)
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long telopods, large numbers of mitochondria, dilated
rough endoplasmic reticulum cisternae, and clusters of
shed vesicle.
Every effort has been made to correctly identify telo-
cytes in our study. Positive immunostaining to c-Kit (CD
117) was employed as a marker to recognize telocytes
[10, 30]. Mast cells, which are also c-KIT positive, were
easily distinguished as large round or oval cells with
abundant granular cytoplasm and large round nuclei
[10, 31]. Moreover, strict ultrastructural criteria were
applied to define telocytes under electron microscope.
These included: 1) small cell body (9–15 μm), with
scanty cytoplasm, 2) spindle or triangular shape, 3)
nucleus with moderately dense chromatin, and, 4)
most characteristically, the presence of telopodes,
identified as very long cytoplasmic processes (2–5 per
cell) with a branching pattern and a “bead on string”
appearance [9, 10].
In agreement with our results are the findings of previ-
ous studies in which telocytes have been identified in the
human myometrium [10, 30, 32–34]. The function of
telocytes in the myometrium is still controversial. Being
morphologically similar to Interstitial Cells of Cajal
(ICC) of the GIT that regulate gut motility, uterine telo-
cytes are assumed to be the pace maker controlling
myometrial contractions. Supporting this concept is
electrophysiological data showing that myometrial telo-
cytes of the non pregnant uterus exhibit hyperpolarizing
chloride inward current with calcium dependence
indicating a role in myometrial excitability [10, 26, 35].
Telocytes are also involved in intercellular signaling
throughout the myometrium and involved in the process
of myometrial regeneration [10, 36]. As telocytes com-
municate with immune cells within the myometrium,
these specialized cells may play a role in the immune
tolerance to pregnancy [37].
Although our study lacked functional experiments, but
our observation of increased telocyte cell number and
activity in ULM point out an active role of these cells in
ULM development and/or growth.
The cellular origin of ULM is not exactly known. Early
genetic studies have indicated that ULMs are monoclonal
in origin [38]. It is reported that mouse and human myo-
metrium contain multipotent stem cells that are respon-
sible for tissue regeneration [39, 40]. Similarly, uterine
leiomyomas were shown to contain a side population of
cells that show phenotypic and functional characteristics of
fibroid stem cells [41], which are believed to give origin to
fibroid tumors under influence of steroid hormones [42].
To be accepted as cells of origin of such highly steroid
dependent tumors, fibroid stem cells should have a
mechanism to respond to estrogen and progesterone.
However, the side population of fibroid stem cells con-
tains very little amounts of steroid hormone receptors
[41, 42]. It is postulated that estrogen and progesterone
work on the nearby steroid hormone receptor positive
mature myometrial and fibroid cells releasing paracrine
factors that stimulate the fibroid stem cells to mediate
tumor growth [1]. Telocytes can fit nicely into that
model. They have been shown to express estrogen and
progesterone receptors in their cell bodies and in cellular
processes [43, 44]. Moreover, they keep an extensive net-
work of intercellular communication within the myome-
trium, and as our findings indicate, within the ULM as
well. Based on our findings and those of others, we can
postulate that telocytes may work as hormonal sensors
for uterine leiomyoma stem cells [44]. Telocytes can re-
spond to estrogen and progesterone hormones through
their expressed steroid hormone receptors, and relay
their signals to the leiomyoma stem cell through their
extensively branching processes.
Telocytes work as part of stem cell niche to form stem
cell/telocyte tandem. In leiomyoma, their interstitial net-
work of telopodes can build a dynamic scaffold surround-
ing the stem cells, which helps to guide the newly formed
leiomyoma cells to form a coherent 3D architecture. Such
a role of telocytes in nursing stem cells has been shown in
cardiac [45, 46], and skeletal muscles [47, 48].
c-KIT (CD 117) expressed by telocytes is a member of
type III trans-membrane receptor tyrosine kinase family.
Binding of the c-KIT receptor to its ligand, stem cell
factor (SCF), results in receptor dimerization and kinase
activation. This leads to subsequent activation of two
important molecular pathways: the mitogen-activated
protein (MAP) kinase pathway (RAF, MEK and ERK),
and phosphoinositide 3-kinase (PI3K) pathway (AKT,
mammalian target of rapamycin (mTOR), S6 kinase). In
addition, signal transducer and activator of transcription
3 (STAT3) is activated. The collective impact favors an
increase in cell metabolism, cell cycle progression, and a
decreased sensitivity to apoptosis [49].
The ERK signaling pathway, (a downstream of MAP
kinase activation) has been shown to be a mediator of
ULM growth [50]. In addition, mTOR signaling, (a
downstream of PI3K activation), is activated in high fre-
quency in ULM [51, 52]. The role of STAT3 in ULM
was elucidated in a study in which tyrosine kinase
inhibitor reduced leiomyoma cell proliferation in vitro
mediated through phosphorylated STAT3 inhibition [53].
Taken together, it appears that c-KIT receptor activa-
tion can stimulate important intracellular pathways that
have been implicated in ULM pathogenesis.
Of interest in our study is the finding that Myo-F
contained fewer telocytes than the Myo-N, although the
difference did not reach statistical significance. In the
gastrointestinal tract, disorders characterized by exces-
sive fibrosis, such as ulcerative colitis, Crohn’s disease,
are associated with marked reduction in number and/or
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ultrastructural damage to the affected tissue telocytes
[29, 54, 55]. This contributes to the loss of function and
dysmotility encountered in the affected structures such
as colon or stomach [54]. A similar concept can be ex-
trapolated to the fibroid uterus, where excessive extra-
cellular matrix deposition in ULM is associated with
reduction in telocytes number in Myo-F. This can lead
to disturbed tissue homeostasis and abnormal contrac-
tion waves in the uterus which can be associated with
infertility or dysmenorrhea observed in ULM patients.
Alternatively, as telocytes show some degree of motility
[13], the reduced number of telocytes in Myo-F compared
to Myo-N, may be explained on the basis of migration
and recruitment of myometrial telocytes to the region of
the ULM.
Further supporting our data on ULMs are previous
studies implicating telocytes in the pathogenesis of cancer
[56]. Telocytes had potential functions in self-assembly of
normal breast stromal, and breast cancer cells to self- as-
sembly breast cancer tissue in vitro. Telocyte-like cells
closely communicated with breast cancer cells as well as
other stromal cells, and might serve as a bridge that dir-
ectly linked the adjacent cells [57]. In the skin, and in
comparison to telocytes from normal dermis, telocytes
from basal and squamous cell carcinoma of the skin
showed limitation in their heterocellular junctions. This
suggests a possible involvement in induction of cell-cell
communication into the tumor [58].
c-KIT expressed by telocytes is amenable for pharma-
cological manipulation. Imatinib, a 2-phenyl amino pyr-
imidine derivative, is a tyrosine kinase inhibitor with
activity against c-KIT. It works by binding close to the
ATP binding site on the tyrosie kinase, locking it in a
closed conformation. This process ultimately results in
“switching-off” the downstream signaling pathways [59],
some of which are essentially important in uterine ULM
growth. Imatinib is used as a molecularly targeted ther-
apy for the treatment of cancers such as chronic myeloid
leukemia or gastrointestinal stromal tumors (GIST). The
drug is given orally and generally well tolerated, with
serious side effects rarely happening [60].
Conclusions
In conclusion, telocytes are detected in higher numbers
and activity in ULM than Myo-F or Myo-N. In ULM,
telocytes can form a tandem with stem cells working as
a hormonal sensors and/or nursing stem cells. c-KIT
expressed by telocytes controls downstream signaling
pathways essential for ULM growth. c-KIT receptors on
human ULMs can be blocked by tyosine kinase inhibi-
tors such as imatinib. This may represent a therapeutic
option for human ULMs.
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